EUR J PREV CARDIOL 润色咨询

European Journal of Preventive Cardiology

出版年份：暂无数据 年文章数：1221 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：21.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2025-05-18 ms2000000650808993 来自上海

    5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2023-12-07 ms7000000465698001 来自重庆

    请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2025-05-17 1ddccb01m45(暂无匿称) 来自广东省

    4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2018-07-26 gll19890429

    EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ...................

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2025-06-17 ms3000000269819517 来自贵州省

    想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2025-06-06 1487fc82m62(暂无昵称) 来自湖北省

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向：心血管预防
    经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2025-05-15 ms4000000138814692 来自广东省

    赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2024-05-22 清清欢 来自江西省

    偏重的研究方向：心血管
    经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2024-08-29 小乐fight 来自江苏省

    20天，还在underreview

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2265626, encodeId=9967226562686, content=5.11号投稿，目前还是Submitted to Journal，Status Date一直都是5.11，这正常吗。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1f68232279, createdName=ms2000000650808993, createdTime=Sun May 18 22:15:38 CST 2025, time=2025-05-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2173559, encodeId=50ca21e3559b9, content=请问一下这个杂志一般submitted to journal持续多久啊，我已经两周了😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1884, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83e38218162, createdName=ms7000000465698001, createdTime=Thu Dec 07 20:00:55 CST 2023, time=2023-12-07, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2265515, encodeId=a9a6226551583, content=4-30投稿，5天后状态为with editor，5-17仍然处于这个状态，官网说处理稿件很快，一审就2周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/IRJ7eO6DmdWicRgxO6ka2BZ4CAeEMy8ZKWIfz7TDKA1ibzKutMicHN8E6o9wZGE0dN4R5uK3cyHbpWCiatxSqeSNTQ/132, createdBy=eaca1651997, createdName=1ddccb01m45(暂无匿称), createdTime=Sat May 17 22:21:24 CST 2025, time=2025-05-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=559574, encodeId=e3f05595e4b0, content=EJPC-D-18-00502 一篇meta 21 Jun 2018 14 Jul 2018 Required Reviews Completed 到现在还是这个状态 内心忐忑 ..................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2756, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00a1106782, createdName=gll19890429, createdTime=Thu Jul 26 10:59:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2269772, encodeId=9ae12269e72a3, content=想问一下提交后，给每位作者发的利益声明，必须每位作者同意后才能进去下一步吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44049006699, createdName=ms3000000269819517, createdTime=Tue Jun 17 21:13:45 CST 2025, time=2025-06-17, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2268123, encodeId=90df2268123c4, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向：心血管预防<br>经验分享：对创新要求比较高，或者临床意义明确，录用率只有5%到7%，官方邮件给的数据。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=565f5308195, createdName=1487fc82m62(暂无昵称), createdTime=Fri Jun 06 00:52:23 CST 2025, time=2025-06-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2265160, encodeId=9d3622651607c, content=赶在2025-4-30投稿，5天后with editor，目前仍停留在这个状态，官网说一审2w左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a47a5540335, createdName=ms4000000138814692, createdTime=Thu May 15 11:59:15 CST 2025, time=2025-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2205975, encodeId=d3c122059e5e9, content=偏重的研究方向：心血管<br>经验分享：2024～5～17投稿，提交至期刊，21号w i t h e d i t o r，21号d e c i s o n i n p r o c e s s, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1203, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Wed May 22 11:03:13 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2223128, encodeId=cd442223128ea, content=20天，还在underreview, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84585535345, createdName=小乐fight, createdTime=Thu Aug 29 22:41:27 CST 2024, time=2024-08-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2093734, encodeId=b6212093e3466, content=with editor后直接没有under review直接Decision in Process是不是要被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2401, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9c8225804, createdName=ms2000001658692497, createdTime=Fri Oct 14 08:45:03 CST 2022, time=2022-10-14, status=1, ipAttribution=)]
    2022-10-14 ms2000001658692497

    with editor后直接没有under review直接Decision in Process是不是要被拒了？

    5

    展开5条回复
共85条页码: 1/9页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分